Emphasis of FAS/FASL gene polymorphism in patients with non-muscle invasive bladder cancer.
Gülay Güleç CeylanSedat YahşiSerkan DoğanElife ÖztÜrkGulay CeylanPublished in: Irish journal of medical science (2018)
Evaluation of FAS/FASL polymorphisms can predict lack of response to BCG immunotherapy and prevent the loss of valuable time before such alternative treatments as early cystectomy are initiated.